Commons Capital’s Bristol-Myers Squibb BMY Stock Holding History

Commons Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$450K	Sell	7,417 -620	-8%	-$36.1K	0.38%	48
2025 Q4	$434K	Sell	8,037 -345	-4%	-$16.6K	0.29%	63
2025 Q3	$378K	Sell	8,382 -244	-3%	-$11.4K	0.25%	71
2025 Q2	$399K	Buy	8,626 +56	+0.7%	+$2.75K	0.3%	60
2025 Q1	$523K	Buy	8,570 +70	+0.8%	+$4.08K	0.48%	46
2024 Q4	$481K	Sell	8,500 -28	-0.3%	-$1.56K	0.43%	52
2024 Q3	$441K	Sell	8,528 -18	-0.2%	-$844	0.49%	36
2024 Q2	$355K	Buy	+8,546	New	+$382K	0.43%	34
2023 Q2	–	Sell	-3,907	Closed	-$271K	–	65
2023 Q1	$271K	Sell	3,907 -1,130	-22%	-$79.7K	0.43%	50
2022 Q4	$362K	Buy	5,037 +22	+0.4%	+$1.66K	0.6%	45
2022 Q3	$357K	Buy	5,015 +23	+0.5%	+$1.67K	0.57%	48
2022 Q2	$384K	Buy	4,992 +2,140	+75%	+$163K	0.58%	51
2022 Q1	$208K	Buy	2,852 +13	+0.5%	+$873	0.22%	102
2021 Q4	$177K	Buy	+2,839	New	+$167K	0.18%	116

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Commons Capital's BMY Position: Q1 2026 in Review

Commons Capital reduced its Bristol-Myers Squibb (BMY) stake by 7.7% in Q1 2026, selling an estimated $36.1K and leaving 7,417 shares worth $450K. The position accounts for 0.38% of the portfolio, ranked #48.

Commons Capital first reported a position in BMY in Q4 2021 and has held it in 14 quarters since. The position peaked at $523K in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Commons Capital held 7,417 shares of Bristol-Myers Squibb worth $450K as of Q1 2026.
Commons Capital sold 620 Bristol-Myers Squibb shares in Q1 2026, an estimated $36.1K.
Bristol-Myers Squibb made up 0.38% of Commons Capital's portfolio in Q1 2026, its #48 holding.
Commons Capital first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 14 quarters since.
Commons Capital's Bristol-Myers Squibb position peaked at $523K in Q1 2025.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Commons Capital's 13F filing for Q1 2026, filed 30 Apr 2026.